rs2077527201

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_001029891.3(PGAM4):​c.596G>C​(p.Gly199Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000413 in 1,210,269 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.0000036 ( 0 hom. 1 hem. )

Consequence

PGAM4
NM_001029891.3 missense

Scores

1
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.51

Publications

0 publications found
Variant links:
Genes affected
PGAM4 (HGNC:21731): (phosphoglycerate mutase family member 4) This intronless gene appears to have arisen from a retrotransposition event, yet it is thought to be an expressed, protein-coding gene. The encoded protein is a member of the phosphoglycerate mutase family, a set of enzymes that catalyze the transfer of a phosphate group from 3-phosphoglycerate to 2-phosphoglycerate. [provided by RefSeq, May 2010]
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26792303).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PGAM4NM_001029891.3 linkc.596G>C p.Gly199Ala missense_variant Exon 1 of 1 ENST00000458128.3 NP_001025062.1 Q8N0Y7
ATP7ANM_000052.7 linkc.-21-2578C>G intron_variant Intron 1 of 22 ENST00000341514.11 NP_000043.4 Q04656-1B4DRW0Q762B6
ATP7ANM_001282224.2 linkc.-21-2578C>G intron_variant Intron 1 of 21 NP_001269153.1 Q04656-5B4DRW0Q762B6
ATP7ANR_104109.2 linkn.144-2578C>G intron_variant Intron 1 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PGAM4ENST00000458128.3 linkc.596G>C p.Gly199Ala missense_variant Exon 1 of 1 6 NM_001029891.3 ENSP00000412189.1 Q8N0Y7
ATP7AENST00000341514.11 linkc.-21-2578C>G intron_variant Intron 1 of 22 1 NM_000052.7 ENSP00000345728.6 Q04656-1

Frequencies

GnomAD3 genomes
AF:
0.00000890
AC:
1
AN:
112368
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000938
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000364
AC:
4
AN:
1097901
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
1
AN XY:
363417
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26390
American (AMR)
AF:
0.000114
AC:
4
AN:
35201
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54121
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3923
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
842077
Other (OTH)
AF:
0.00
AC:
0
AN:
46065
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000890
AC:
1
AN:
112368
Hom.:
0
Cov.:
22
AF XY:
0.0000290
AC XY:
1
AN XY:
34512
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30921
American (AMR)
AF:
0.0000938
AC:
1
AN:
10656
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2738
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6161
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53235
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 05, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.596G>C (p.G199A) alteration is located in exon 1 (coding exon 1) of the PGAM4 gene. This alteration results from a G to C substitution at nucleotide position 596, causing the glycine (G) at amino acid position 199 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.022
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.33
T
FATHMM_MKL
Benign
0.62
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.27
T
MetaSVM
Benign
-0.55
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
5.5
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.29
Sift
Uncertain
0.027
D
Sift4G
Benign
0.081
T
Polyphen
0.094
B
Vest4
0.30
MutPred
0.40
Loss of ubiquitination at K195 (P = 0.094);
MVP
0.87
MPC
0.62
ClinPred
0.88
D
GERP RS
0.12
Varity_R
0.26
gMVP
0.80
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2077527201; hg19: chrX-77224540; API